Bristol Myers Squibb Co

Tredje AP-fonden BMY

Report date

6/30/2026

Quarter

2026 Q2

Filed

8/10/2026

Shares

690,291

Value ($000)

39,775

Weight

0.2%

2019 Q4 - 2026 Q2 (20 filings)

Shares History

History scope: non-option holdings only (PUT/CALL rows excluded).

All 13F Holders	Filing date	Value ($000s)	% of Holdings	Shares	Reporting period
2026 Q2	8/10/2026	39,775	0.2%	690,291	6/30/2026
2026 Q1	5/12/2026	36,637	0.2%	604,075	3/31/2026
2024 Q1	5/13/2024	8,979	0.1%	165,581	3/31/2024
2023 Q4	2/12/2024	13,463	0.2%	262,381	12/31/2023
2023 Q3	11/9/2023	29,272	0.4%	504,341	9/30/2023
2023 Q2	8/11/2023	32,155	0.5%	502,812	6/30/2023
2023 Q1	5/10/2023	36,611	0.6%	528,224	3/31/2023
2022 Q4	2/10/2023	36,182	0.6%	502,875	12/31/2022
2022 Q3	11/10/2022	30,482	0.6%	428,778	9/30/2022
2022 Q2	8/11/2022	27,404	0.7%	355,890	6/30/2022
2022 Q1	5/9/2022	25,260	0.5%	345,890	3/31/2022
2021 Q4	2/10/2022	19,571	0.4%	313,890	12/31/2021
2021 Q3	11/10/2021	19,075	0.4%	322,368	9/30/2021
2021 Q2	8/6/2021	16,529	0.3%	247,368	6/30/2021
2021 Q1	5/10/2021	15,616	0.4%	247,368	3/31/2021
2020 Q4	2/12/2021	15,344	0.4%	247,368	12/31/2020
2020 Q3	11/10/2020	14,914	0.5%	247,368	9/30/2020
2020 Q2	8/11/2020	14,545	0.6%	247,368	6/30/2020
2020 Q1	5/28/2020	20,341	1.1%	364,929	3/31/2020
2019 Q4	2/10/2020	18,543	0.9%	288,881	12/31/2019